Top 10 egfrcancer.org competitors & alternatives
[EGFR Lung Cancer Resisters Group Patient-driven advocacy group united with the goal of finding a cure for EGFR lung cancer. Join EGFR Lung Cancer Resisters advocacy group today!]
egfrcancer.org competitors and alternatives
Top 10 egfrcancer.org competitors and alternatives are ranked by similar search terms, traffic and worth.
egfrcancer.org's top 5 competitors are: mycancergenome.org with 14,500 daily traffic and 166,300 estimated worth, lcfamerica.org with 0 daily traffic and 79,600 estimated worth, lungcancercanada.ca with 0 daily traffic and 11,700 estimated worth, tarceva.com with 0 daily traffic and 11,400 estimated worth, lcam.org with 0 daily traffic and 7,800 estimated worth.
lcfamerica.org
Lung Cancer Foundation of America: Research and Awareness
Lung Cancer Foundation of America mission is dedicated to improving survivorship by funding transformative lung cancer research. Learn how you can help.
Daily Traffic: 0
Website Worth: $ 79,600
lungcancercanada.ca
Lung Cancer Canada - Lung Cancer Canada
faces of lung cancer report putting a spotlight on lung cancer, and elevating the voice of those with lived experience. read the report now find…
Daily Traffic: 0
Website Worth: $ 11,700
tarceva.com
Tarceva® (erlotinib) for Advanced Non-Small Cell Lung Cancer (NSCLC) Treatment
Information about Tarceva® (erlotinib) tablets as maintenance treatment for advanced stage non-small cell lung cancer (NSCLC).
Tarceva is prescribed for patients with advanced-stage non-small cell lung cancer (NSCLC) whose cancer has not spread or grown after initial treatment with certain types of chemotherapy. (Maintenance treatment)
Tarceva is prescribed for patients with advanced-stage non-small cell lung cancer (NSCLC) whose cancer has spread or grown after receiving at least 1 chemotherapy regimen. (2nd-/3rd-line treatment)
Tarceva is not meant to be used at the same time as certain types of chemotherapy for NSCLC.
Important Safety Information
Possible effects on the lungs
There have been reports of serious adverse events involving the lungs in a small number of patients taking Tarceva. These events have included death in some patients. The medical name for these types of events is interstitial (in-tur-STISH-ul) lung disease-like events (or ILD-like events).
Possible effects on the kidneys and liver
Liver and/or kidney problems (including deaths) have been reported in some patients taking Tarceva. Let your healthcare provider (HCP) know if you have a history of liver or kidney disease.
Possible effects on the stomach and intestines
Some patients taking Tarceva have developed a hole in the lining of their stomach or intestines (including deaths). It may happen more in patients who are taking certain other medicines or who have had certain stomach or intestinal diseases.
Possible effects on the skin
Some patients taking Tarceva have developed serious skin conditions. Some patients have died from these conditions.
Possible effects on the eye
Some patients taking Tarceva have developed eye irritation and damage to the cornea. The cornea is the clear part of the eyeball that covers the colored part of the eye and the pupil. Other eye problems such as abnormal eyelash growth, dry eyes, or changes in eyesight have also been reported. Patients should
Daily Traffic: 0
Website Worth: $ 11,400
lcam.org
Lung Cancer Awareness Month | November is Lung Cancer Awareness Month. Hope Lives. More Research. More Survivors.
Lung Cancer Awareness Month | November is Lung Cancer Awareness Month. Hope Lives. More Research. More Survivors.
Daily Traffic: 0
Website Worth: $ 7,800
tagrisso.com
Treatment for Certain Types of EGFR+ NSCLC | TAGRISSO® (osimertinib)
Learn about TAGRISSO® (osimertinib), a targeted treatment option for people with certain types of EGFR+ non-small cell lung cancer (NSCLC). Talk to your doctor to see if TAGRISSO is right for you.
Daily Traffic: 0
Website Worth: $ 0
Share on Social Media
Similar sites like egfrcancer.org